A Phase 3b, Multicenter, Clinical Trial to Evaluate Pulmonary Function in a Subset of Subjects With Type 1 or Type 2 Diabetes.
Phase of Trial: Phase III
Latest Information Update: 05 Dec 2012
At a glance
- Drugs Insulin (Primary)
- Indications Type 1 diabetes mellitus; Type 2 diabetes mellitus
- Focus Adverse reactions
- Sponsors MannKind Corporation
- 14 Jul 2011 Actual end date (October 2010) added as reported by ClinicalTrials.gov.
- 14 Jul 2011 Planned End Date changed from 1 Dec 2011 to 1 Jun 2011 as reported by ClinicalTrials.gov. 992332
- 14 Jul 2011 Status changed from not yet recruiting to discontinued as reported by ClinicalTrials.gov.